Ignite Creation Date:
2025-12-25 @ 2:38 AM
Ignite Modification Date:
2025-12-31 @ 5:42 PM
Study NCT ID:
NCT01012934
Status:
COMPLETED
Last Update Posted:
2009-11-13
First Post:
2009-09-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Fasting Study of Alendronate Sodium Tablets (70 mg) and Fosamax Tablets (70 mg)
Sponsor:
Mylan Pharmaceuticals Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2002-07
Start Date Type:
None
Primary Completion Date:
2002-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2002-08
Completion Date Type:
ACTUAL
First Submit Date:
2009-09-21
First Submit QC Date:
None
Study First Post Date:
2009-11-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2009-11-12
Last Update Post Date:
2009-11-13
Last Update Post Date Type:
ESTIMATED